Around 20-30% of patients stop taking aromatase inhibitors because of side effects like joint pain, bone loss, or other discomforts. Many people find that switching to another aromatase inhibitor will reduce or eliminate their symptoms, and allow them to continue to benefit from the anti cancer effects of aromatase inhibitors.